Centre For Digestive And Kidney Diseases (India) Profile
Key Indicators
- Authorised Capital ₹ 190.00 Cr
- Paid Up Capital ₹ 184.00 Cr
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 423.04 Cr
- Satisfied Charges ₹ 668.92 Cr
- Revenue Growth 6.25%
- Profit Growth 11.89%
- Ebitda 3.27%
- Net Worth 113.25%
- Total Assets 6.31%
About Centre For Digestive And Kidney Diseases (India)
Centre For Digestive And Kidney Diseases (India) Private Limited (CFDAKDIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 April 2004 and has a history of 20 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 190.00 Cr and a paid-up capital of Rs 184.00 Cr.
The company currently has active open charges totaling ₹423.04 Cr. The company has closed loans amounting to ₹668.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Centre For Digestive And Kidney Diseases (India) Private Limited India is Aanchal Vig as COMPANY SECRETARY. Jayasinh Mariwala, Anurag Yadav, Bharat Shah, and Nine other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110MH2004PTC146014
- Company No.
146014
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2004
- Date of AGM
11 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Centre For Digestive And Kidney Diseases (India) Private Limited offer?
Centre For Digestive And Kidney Diseases (India) Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Pharmaceutical Chemists.
Who are the key members and board of directors at Centre For Digestive And Kidney Diseases (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aanchal Vig  | Company Secretary | Current |
Board Members (12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Rao | Director | 02-Jan-2005 | Current |
| Pradeep Rao | Additional Director | Current | |
| Bharat Shah | Director | 30-Apr-2004 | Current |
| Jayasinh Mariwala | Director | 02-Jan-2005 | Current |
| Anurag Yadav | Nominee Director | 20-Feb-2018 | Current |
| Ashok Bajpai | Nominee Director | 26-Sep-2019 | Current |
Financial Performance of Centre For Digestive And Kidney Diseases (India).
Centre For Digestive And Kidney Diseases (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.25% increase. The company also saw a substantial improvement in profitability, with a 11.89% increase in profit. The company's net worth Soared by an impressive increase of 113.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Centre For Digestive And Kidney Diseases (India)?
In 2023, Centre For Digestive And Kidney Diseases (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parkway Healthcare India Private LimitedAnurag Yadav, Kok Lai and 1 more are mutual person
Gleneagles Clinical Research Services (India) Private LimitedAnurag Yadav and Jean Naa are mutual person
Auto Hangar (India) Private LimitedJayasinh Mariwala is a mutual person
Vallabhdas Kanji LimitedJayasinh Mariwala is a mutual person
Food Service (India) Private LimitedJayasinh Mariwala is a mutual person
Ekopath Metropolis Lab Services Private LimitedRakesh Agarwal is a mutual person
Charges (Loans)
₹423.04 Cr
₹668.92 Cr
Charges Breakdown by Lending Institutions
- The Hongkong And Shanghai Banking Corporation Limited : 423.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹211.52 Cr | Open |
| 29 Dec 2021 | The Hongkong And Shanghai Banking Corporation Limited | ₹211.52 Cr | Open |
| 28 Jun 2021 | Axis Bank Limited | ₹7.93 Cr | Satisfied |
| 28 Jun 2021 | Axis Bank Limited | ₹35.52 Cr | Satisfied |
| 22 Oct 2018 | Axis Bank Limited | ₹220.00 Cr | Satisfied |
How Many Employees Work at Centre For Digestive And Kidney Diseases (India)?
Unlock and access historical data on people associated with Centre For Digestive And Kidney Diseases (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centre For Digestive And Kidney Diseases (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centre For Digestive And Kidney Diseases (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
